LON:GSK GSK (GSK) Share Price, News & Analysis GBX 1,448.50 -7.00 (-0.48%) (As of 10/25/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability About GSK Stock (LON:GSK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GSK alerts:Sign Up Key Stats Today's Range 1,434.85▼ 1,452.5050-Day Range 1,448▼ 1,67152-Week Range 1,371.40▼ 1,823.50Volume4.80 million shsAverage Volume10.15 million shsMarket Capitalization£59.10 billionP/E Ratio1,281.86Dividend Yield4.14%Price TargetGBX 1,842.50Consensus RatingModerate Buy Company OverviewGSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.Read More… Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… GSK Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks69th Percentile Overall ScoreGSK MarketRank™: GSK scored higher than 69% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingGSK has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 5 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageGSK has only been the subject of 4 research reports in the past 90 days.Read more about GSK's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of GSK is 1,281.86, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 128.13.Price to Earnings Ratio vs. SectorThe P/E ratio of GSK is 1,281.86, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 108.89.Price to Earnings Growth RatioGSK has a PEG Ratio of 1.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGSK has a P/B Ratio of 4.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GSK. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipGSK is a leading dividend payer. It pays a dividend yield of 3.99%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthGSK does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of GSK is 5,309.73%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about GSK's dividend. Sustainability and ESG4.4 / 5Environmental Score-1.56 Short InterestThere is no current short interest data available for GSK. News and Social Media2.9 / 5News Sentiment0.25 News SentimentGSK has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for GSK this week, compared to 6 articles on an average week.Search Interest35 people have searched for GSK on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days.MarketBeat Follows1 people have added GSK to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, GSK insiders have bought more of their company's stock than they have sold. Specifically, they have bought £9,267.86 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 1.61% of the stock of GSK is held by insiders.Percentage Held by Institutions45.33% of the stock of GSK is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about GSK's insider trading history. Receive GSK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Stock News HeadlinesGSK stays in red for seven straight sessionsOctober 25 at 6:19 PM | msn.comGSK invests $800M in manufacturing; Amgen sets small discount for Eylea biosimilarOctober 25 at 1:18 PM | finance.yahoo.comAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released my latest prediction and believe it or not, I’m advising NOT pour all your money into Nvidia right nowOctober 26, 2024 | Brownstone Research (Ad)GSK pumps up to $800m for US manufacturing site upgradeOctober 25 at 1:18 PM | finance.yahoo.comGSK to invest up to $800M in Pennsylvania siteOctober 25 at 8:17 AM | markets.businessinsider.comGSK plans $800M expansion of Pennsylvania drug manufacturing facilitiesOctober 25 at 8:17 AM | bizjournals.comGSK investing up to $800 million in Lancaster County facility expansionOctober 24 at 10:14 PM | msn.comHaleon: Too Vanilla For My Liking - I See Why GSK & Pfizer Wanted OutOctober 24 at 10:14 PM | seekingalpha.comSee More Headlines GSK Stock Analysis - Frequently Asked Questions How have GSK shares performed this year? GSK's stock was trading at GBX 1,450.20 at the beginning of 2024. Since then, GSK stock has decreased by 0.1% and is now trading at GBX 1,448.50. View the best growth stocks for 2024 here. How were GSK's earnings last quarter? GSK plc (LON:GSK) announced its quarterly earnings results on Wednesday, July, 29th. The company reported $56.90 earnings per share for the quarter. GSK had a trailing twelve-month return on equity of 33.30% and a net margin of 12.83%. How do I buy shares of GSK? Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of GSK own? Based on aggregate information from My MarketBeat watchlists, some other companies that GSK investors own include AstraZeneca (AZN), Vodafone Group Public (VOD), Lloyds Banking Group (LLOY), Secure Trust Bank (STB), Barclays (BARC), Meta Platforms (META) and Intel (INTC). Company Calendar Last Earnings7/29/2020Ex-Dividend for 10/10 Dividend8/15/2024Dividend Payable10/10/2024Today10/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - General Sub-IndustryPharmaceutical Products Current SymbolLON:GSK CUSIPN/A CIKN/A Webwww.gsk.com Phone+44-20-80475000FaxN/AEmployees70,212Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 1,842.50 High Stock Price TargetGBX 2,100 Low Stock Price TargetGBX 1,660 Potential Upside/Downside+27.2%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 1.13 Trailing P/E Ratio1,281.58 Forward P/E Ratio8.23 P/E Growth1.24Net Income£4.03 billion Net Margins12.83% Pretax MarginN/A Return on Equity33.30% Return on Assets9.56% Debt Debt-to-Equity Ratio123.04 Current Ratio0.82 Quick Ratio0.73 Sales & Book Value Annual Sales£31.45 billion Price / Sales1.88 Cash FlowGBX 177.79 per share Price / Cash Flow8.15 Book ValueGBX 352 per share Price / Book4.11Miscellaneous Outstanding Shares4,080,000,000Free FloatN/AMarket Cap£59.09 billion OptionableNot Optionable Beta0.31 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (LON:GSK) was last updated on 10/26/2024 by MarketBeat.com Staff From Our PartnersAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored“Hear That Whoosh Sound? It’s the Great Power Suck of 2025”We’re coming to the end of the line for the traditional energy grid. Look what’s happening in California.Traders Agency | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredPutin proposes new currencyRussian leader Vladimir Putin just unveiled the first physical mockup of a proposed new currency. Many spec...Stansberry Research | SponsoredONE crypto stock +526% in under 60 daysCryptos are screaming higher right now. Yet, this ONE started a shooting up a little under 60 days ago.The Bitcoin Capitalist | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.